OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 92 citing articles:

Pediatric hemophagocytic lymphohistiocytosis
Scott Canna, Rebecca Marsh
Blood (2020) Vol. 135, Iss. 16, pp. 1332-1343
Open Access | Times Cited: 359

Signaling pathways involved in the T‐cell‐mediated immunity against Epstein‐Barr virus: Lessons from genetic diseases
Sylvain Latour, Alain Fischer
Immunological Reviews (2019) Vol. 291, Iss. 1, pp. 174-189
Closed Access | Times Cited: 100

Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection
Stuart G. Tangye, Sylvain Latour
Blood (2020) Vol. 135, Iss. 9, pp. 644-655
Open Access | Times Cited: 93

Predisposition to cancer in children and adolescents
Christian P. Kratz, Marjolijn C.J. Jongmans, Hélène Cavé, et al.
The Lancet Child & Adolescent Health (2021) Vol. 5, Iss. 2, pp. 142-154
Closed Access | Times Cited: 92

Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency
Sujal Ghosh, Sevgi Köstel Bal, Emily S.J. Edwards, et al.
Blood (2020) Vol. 136, Iss. 23, pp. 2638-2655
Open Access | Times Cited: 80

Human inborn errors of immunity to herpes viruses
Emmanuelle Jouanguy, Vivien Béziat, Trine H. Mogensen, et al.
Current Opinion in Immunology (2020) Vol. 62, pp. 106-122
Open Access | Times Cited: 74

Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity
Georgios Sogkas, Faranaz Atschekzei, Ignatius Ryan Adriawan, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1122-1140
Open Access | Times Cited: 62

Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases
Mark Ballow, Silvia Sánchez‐Ramón, Jolán E. Walter
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43

Diagnostic testing for hemophagocytic lymphohistiocytosis
Rebecca Marsh, Jack Bleesing, Samuel C. C. Chiang
Journal of Immunological Methods (2025), pp. 113816-113816
Closed Access | Times Cited: 1

Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency
Mohammed F. Alosaimi, Manfred Hoenig, Faris Jaber, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 2, pp. 574-583.e5
Open Access | Times Cited: 70

Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells
Rémy Rodriguez, Benjamin Fournier, Débora Jorge Cordeiro, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 12, pp. 2800-2818
Open Access | Times Cited: 69

An Update on XMEN Disease
Juan C. Ravell, Samuel D. Chauvin, Tingyan He, et al.
Journal of Clinical Immunology (2020) Vol. 40, Iss. 5, pp. 671-681
Open Access | Times Cited: 63

CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID
Pavlína Králíčková, Tomáš Milota, Jiří Litzman, et al.
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 55

Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection
Benjamin Fournier, David Boutboul, Julie Bruneau, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 11
Open Access | Times Cited: 51

Virological Markers in Epstein–Barr Virus-Associated Diseases
Julien Lupo, Aurélie Truffot, Julien Andréani, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 656-656
Open Access | Times Cited: 19

Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses
Blossom Damania, Christian Münz
FEMS Microbiology Reviews (2018) Vol. 43, Iss. 2, pp. 181-192
Open Access | Times Cited: 59

DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
Loredana Cifaldi, Margherita Doria, Nicola Cotugno, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 15, pp. 3715-3715
Open Access | Times Cited: 50

Genetic susceptibility to EBV infection: insights from inborn errors of immunity
Stuart G. Tangye
Human Genetics (2020) Vol. 139, Iss. 6-7, pp. 885-901
Closed Access | Times Cited: 45

CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells
Rebeca Arroyo Hornero, Christos Georgiadis, Hua Peng, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 45

Virus-Mediated Suppression of the Antigen Presentation Molecule MR1
Brian P. McSharry, Carolyn Samer, Hamish E. G. McWilliam, et al.
Cell Reports (2020) Vol. 30, Iss. 9, pp. 2948-2962.e4
Open Access | Times Cited: 41

Mycobacterial diseases in patients with inborn errors of immunity
Stéphanie Boisson‐Dupuis, Jacinta Bustamante
Current Opinion in Immunology (2021) Vol. 72, pp. 262-271
Open Access | Times Cited: 37

CD27 is required for protective lytic EBV antigen–specific CD8+ T-cell expansion
Yun Deng, Bithi Chatterjee, Kyra D. Zens, et al.
Blood (2021) Vol. 137, Iss. 23, pp. 3225-3236
Open Access | Times Cited: 29

Applications of cell therapy in the treatment of virus-associated cancers
Keri Toner, Chase D. McCann, Catherine M. Bollard
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 10, pp. 709-724
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top